Chennai Meenakshi Multispeciality Hospital Ltd.
| BSE: 523489 | Sector: Health care |
| NSE: N.A. | ISIN Code: INE889F01017 |
| BSE 10:39 | 21 Jun | 12.98 |
0 (0.00%) |
OPEN
12.98 |
HIGH
12.98 |
LOW
12.98 |
| NSE 05:30 | 01 Jan | Chennai Meenakshi Multispeciality Hospital Ltd |
| OPEN | 12.98 |
| PREVIOUS CLOSE | 12.98 |
| VOLUME | 241 |
| 52-Week high | 17.34 |
| 52-Week low | 8.10 |
| P/E | |
| Mkt Cap.(Rs cr) | 10 |
| Buy Price | 12.98 |
| Buy Qty | 1.00 |
| Sell Price | 0.00 |
| Sell Qty | 0.00 |
Chennai Meenakshi Multispeciality Hospital Ltd. (CHENNAIMEENA) - Net Sales
Market Cap
| COMPANY | LATEST(Rs) | CHG | CHG(%) | Net Sales (Rs crore) |
| Aurobindo Pharma | 946.00 | -6.30 | -0.66 | 13266.48 |
| Cipla | 951.90 | -8.35 | -0.87 | 12659.15 |
| Sun Pharma.Inds. | 671.75 | 3.35 | 0.50 | 12531.93 |
| Dr Reddy's Labs | 5244.75 | -39.85 | -0.75 | 11850.40 |
| Lupin | 1151.40 | -5.75 | -0.50 | 11025.66 |
| Apollo Hospitals | 3218.95 | -2.95 | -0.09 | 9794.50 |
| Glenmark Pharma. | 645.00 | 4.25 | 0.66 | 6712.63 |
| Alkem Lab | 3126.45 | -10.75 | -0.34 | 6677.08 |
| Cadila Health. | 623.70 | 3.50 | 0.56 | 6347.40 |
| Torrent Pharma. | 2928.10 | 29.75 | 1.03 | 6168.44 |
| Divi's Lab. | 4183.45 | -9.35 | -0.22 | 5310.57 |
| Alembic Pharma | 992.10 | 16.60 | 1.70 | 5051.44 |
| Ipca Labs. | 2035.60 | 44.75 | 2.25 | 4337.82 |
| Piramal Enterp. | 2266.30 | 32.40 | 1.45 | 4219.19 |
| Abbott India | 16499.00 | -8.55 | -0.05 | 4093.14 |
| Glaxosmi. Pharma | 1543.15 | 27.60 | 1.82 | 3224.68 |
| Jubilant Pharmo | 747.00 | 12.40 | 1.69 | 3139.90 |
| Sanofi India | 7607.00 | -21.65 | -0.28 | 2901.90 |
| Laurus Labs | 603.70 | 10.55 | 1.78 | 2797.34 |
| Ajanta Pharma | 1962.55 | 13.05 | 0.67 | 2718.59 |
Quick Links for Chennai Meenakshi Multispeciality Hospital:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
